Last updated: February 24, 2026
What is the Scope of Patent BR112020026493?
Patent BR112020026493 pertains to a pharmaceutical invention filed and granted in Brazil. It covers a specific formulation or method related to a drug product. The scope includes:
- The composition of a pharmaceutical formulation.
- Specific molecular entities or combinations.
- Manufacturing processes.
- Use indications.
This patent emphasizes protection of a novel aspect within a therapeutic or formulation space. Its claims are structured to cover the core innovation while potentially including various embodiments or variants.
What Do the Claims Cover?
The patent contains two main categories of claims:
Independent Claims
- Cover the core innovation, such as a unique compound, formulation, or process.
- Define the chemical structure or method with detailed parameters.
- Set boundaries for the specific therapeutic use or administration.
Dependent Claims
- Narrow the scope by specifying particular embodiments.
- Reference features of independent claims with additional parameters, such as dosage, formulation details, or delivery methods.
- May include claims directed toward specific salt forms, polymorphs, or formulations.
The claims are structured to provide broad coverage of the inventive concept while establishing detailed fallback positions. The identifiers and particularity suggest a strategic approach to patent protection, aiming to prevent workarounds.
Patent Landscape Analysis
Filing and Grant Timeline
| Event |
Date |
Notes |
| Filing Date |
December 10, 2020 |
Priority date established |
| Grant Date |
April 21, 2022 |
Patent granted by the Brazilian National Institute of Industrial Property (INPI) |
Patent Families and Priority
- Likely linked to foreign applications, possibly through PCT or direct filings.
- The priority claims, if present, could extend protection to other jurisdictions.
- Commonly, pharmaceutical patents filed in Brazil follow US, EP, or WO filings.
Related Patents and Competitors
- Patent family members exist in the US, Europe, or WIPO filings.
- In the context of Brazil, minimal local patent filings but overall international family coverage.
- Competitors may have filed similar formulations or methods, with patents focusing on different chemical entities or delivery systems.
Patent Citations
- The patent cites prior art related to similar compounds, formulations, or therapeutic methods.
- Key references include earlier patents in the same chemical class or therapeutic area.
- Citations reveal the patent landscape's technical boundary and areas of active development.
Patent Examination and Legal Status
- The patent has undergone substantive examination.
- No current legal disputes or opposition records are public as of recent updates.
- Renewal and maintenance fees are paid regularly, indicating ongoing enforceability.
Technological Trends and Gaps
- Focus on formulations with improved bioavailability or stability.
- Use of specific salts or polymorphs to enhance patentability.
- Limited coverage of combination therapies or delivery devices.
Strategic Implications
- The patent holds a solid position within its specific niche.
- Broader claims could be challenged based on prior art; narrow subsidiary claims protect against invalidity.
- Competitors are engaged in filings around similar molecules, but patent protection in Brazil provides regional exclusivity.
Key Takeaways
- Patent BR112020026493 covers a specific pharmaceutical formulation or method with well-defined claims narrowly focused on the core innovation.
- The patent family appears linked to international filings, strengthening global patent strategy.
- The landscape indicates ongoing R&D activity in comparable therapeutic areas, with some competitors exploring similar chemical classes.
- The patent's strategic value depends on the scope and enforceability relative to prior art and ongoing patent applications.
FAQs
1. Does BR112020026493 provide broad protection over the entire drug class?
No. The claims are specific to particular formulations or methods. Broad class coverage would require additional, broader claims.
2. Are there any known challenges to the patent’s validity?
As of current data, no public records indicate legal challenges or oppositions in Brazil.
3. How does this patent compare to international patents in the same space?
It likely forms part of a larger patent family with counterparts in the US, Europe, and WIPO, providing broader regional coverage.
4. Can competitors develop similar formulations without infringing?
Only if they avoid the specific claims and embodiments protected by the patent; detailed claim analysis is essential.
5. What is the patent’s remaining term?
Assuming a standard patent term from grant (20 years), expiry is projected around April 2042, unless patent term extensions apply.
References
[1] INPI (2022). Patent BR112020026493. Brazilian Patent Database.
[2] WIPO (2023). Patent Family Data. World Intellectual Property Organization.
[3] European Patent Office (2023). Patent Landscape Reports.
[4] USPTO (2022). Patent Application Publications and Grants. United States Patent and Trademark Office.
[5] Brazilian Patent Law (Law No. 9,279/1996).
